These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31064188)
1. Utilization of Next Generation Sequencing in Analysis of Circulating MicroRNAs as Predictive Biomarkers for Patients with Locally Advanced Rectal Carcinoma. Macháčková T; Grolich T; Fiala L; Procházka V; Škrovina M; Kala Z; Slabý O Klin Onkol; 2019; 32(Supplementum1):157-159. PubMed ID: 31064188 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection. Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193 [TBL] [Abstract][Full Text] [Related]
3. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313 [TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes in Circulating MicroRNA Levels in Liver Cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization. Zavadil J; Juráček J; Čechová B; Andrašina T; Slabý O; Goldberg N Klin Onkol; 2019; 32(Supplementum1):164-166. PubMed ID: 31064190 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125 [TBL] [Abstract][Full Text] [Related]
6. Use of Salivary MicroRNAs for Diagnosis of Solid Cancers. Kubíčková A; Slabý O Klin Onkol; 2018; 31(4):249-259. PubMed ID: 30541306 [TBL] [Abstract][Full Text] [Related]
7. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082 [TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing. Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600 [TBL] [Abstract][Full Text] [Related]
9. Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy. Jo P; Azizian A; Salendo J; Kramer F; Bernhardt M; Wolff HA; Gruber J; Grade M; Beißbarth T; Ghadimi BM; Gaedcke J Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28554991 [TBL] [Abstract][Full Text] [Related]
10. [Usage of Cerebrospinal Fluid for microRNA Analysis]. Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma. D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702 [TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P Crit Rev Oncol Hematol; 2015 Oct; 96(1):67-80. PubMed ID: 26032919 [TBL] [Abstract][Full Text] [Related]
13. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
16. [MicroRNAs in Prediction of Response to Radiotherapy in Head and Neck Cancer Patients - Pilot Study]. Ahmad P; Slavík M; Šána J; Hermanová M; Šlampa P; Smilek P; Kazda T; Slabý O Klin Onkol; 2018; 31(Supplementum1):137-139. PubMed ID: 29808687 [TBL] [Abstract][Full Text] [Related]
17. Current Methods of microRNA Analysis. Bartošík M; Jiráková L Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031 [TBL] [Abstract][Full Text] [Related]
18. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457 [TBL] [Abstract][Full Text] [Related]
19. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study. Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173 [TBL] [Abstract][Full Text] [Related]
20. [Pilot Study on MicroRNAs as Biomarkers of Response to Sunitinib Treatment in Patients with Metastatic Renall Cell Carcinoma]. Kováčová J; Juráček J; Poprach A; Büchler T; Kopecký J; Fiala O; Svoboda M; Lojová M; Slabý O Klin Onkol; 2018; 31(Supplementum1):161-162. PubMed ID: 29808694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]